Probing the mechanism of enzyme-catalyzed reductive dehalogenation for bioremediation
探讨酶催化还原脱卤生物修复的机制
基本信息
- 批准号:RGPIN-2022-04446
- 负责人:
- 金额:$ 6.56万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Organohalide-respiring bacteria (OHRB) are a remarkable group of strictly anaerobic bacteria that use organic compounds with one or several halogen substituents as terminal electron acceptors for energy and growth. A wide variety of naturally occurring and man-made halogenated organic compounds are found in the environment, explaining the widespread distribution of OHRB. In fact, the discovery of this microbial metabolism over 20 years ago revolutionized bioremediation practice. Bioaugmentation, where an aquifer is inoculated with mixed microbial populations of specialized OHRB, is now commonly used for groundwater clean-up, particularly for chlorinated ethenes, ethanes and methanes -all common industrial solvents and widespread toxic pollutants. OHRB are broadly distributed within the Proteobacteria, Chloroflexi, and Firmicutes. Members of the Chloroflexi, particularly Dehalococcoides and Dehalogenimonas, and specific Firmicutes (Dehalobacter) are of exceptional interest because these genera are obligate organohalide respirers. They are ideal for bioremediation because their only metabolism is dehalogenation. The enzymes catalyzing the cleavage of a carbon-halogen bond in OHRB are known as reductive dehalogenases (RDases). RDases contains a vitamin B12 co-factor and two iron sulfur clusters. Thousands of putative sequences have been identified in (meta)genomes from environmental and culture samples, but only a few dozen have been partially characterized. Heterologous expression of functional reductive dehalogenases has been largely unsuccessful, hampering characterization. My research group has developed genomic and proteomic techniques and anaerobic enzyme assays adapted to fastidious anaerobic cultures used for bioremediation. We have managed to identify substrates for a few reductive dehalogenases in their native hosts in enrichment cultures. We developed a classification system to organize putative dehalogenase sequences into hundreds of different ortholog clusters. But the most exciting recent development has been the discovery that by co-expressing a vitamin B12 import pathway with a reductive dehalogenase we could produce active dechorinating enzymes in E. coli. This result finally opens the door to much easier characterization of this extraordinarily useful enzyme family, because we no longer need to produce the enzymes in their slow-growing and genetically intractable native host. Building from this recent finding, the focus of this Discovery Grant is to further mine this novel approach for heterologous expression to 1) rapidly assay the many uncharacterized enzymes on panels of organohalides to identify their substrates and inhibitors, 2) probe mechanism and substrate interactions through structural and mutational analyses, 3) engineer these enzymes for new substrates, including perhaps the problematic perfluorinated compounds, and 4) use this information to inform new remediation approaches.
有机甲虫吸引的细菌(OHRB)是一组显着的厌氧菌细菌,它们使用有机化合物,其中一种或几种卤素取代基作为末端电子受体,用于能量和生长。在环境中发现了各种各样的自然存在和人造卤代有机化合物,解释了OHRB的广泛分布。实际上,20年前这种微生物代谢的发现彻底改变了生物修复实践。生物调节含水层与专门OHRB的混合微生物种群接种的生物层,现在通常用于地下水清理,尤其是用于氯化乙烯,乙烯和甲烷 - 所有常见的工业溶剂和广泛的有毒污染物。 OHRB广泛分布在蛋白质,叶绿体和企业中。氯氟诺夫的成员,尤其是去足球和脱甲虫虫以及特定的企业(脱甲杆菌)的成员具有非凡的兴趣,因为这些属是强大的Organohalide呼吸器。它们是生物修复的理想选择,因为它们唯一的代谢是去alogenation。在OHRB中催化碳释放键的裂解的酶称为还原性去催化酶(RDases)。 RDases含有维生素B12副因素和两个铁硫簇。在环境和培养样品的(元)基因组中已经确定了数千个推定的序列,但仅部分表征了几十个。功能还原性去催化酶的异源表达在很大程度上没有成功,阻碍了特征。 我的研究小组开发了基因组和蛋白质组学技术和厌氧酶测定法,适用于用于生物修复的挑剔的厌氧培养物。我们设法鉴定了其在富集培养物中的原生宿主中一些还原性脱核酶的底物。我们开发了一个分类系统,将推定的脱核酶序列组织成数百个不同的直系同源群。但是,最近最令人兴奋的发展是发现,通过将维生素B12进口途径与还原性脱核酶共同表达,我们可以在大肠杆菌中产生活跃的脱氢酶。最终,这个结果为这种非常有用的酶家族的表征更容易地打开了大门,因为我们不再需要在其缓慢生长且遗传性的本机宿主中产生这些酶。 从这一发现的重点开始,这项发现的重点是进一步挖掘这种新颖的表达方法1)迅速在有机甲降低的有机盐上迅速测定许多未表征的酶,以识别其底物和抑制剂,2)探针机制和底物相互作用,通过结构和突变分析,包括新的组合,包括新的问题,包括新的问题,包括新的问题,包括新的问题,包括新的问题。使用此信息为新的补救方法提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edwards, Elizabeth其他文献
Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation.
- DOI:
10.1002/bit.28066 - 发表时间:
2022-06 - 期刊:
- 影响因子:3.8
- 作者:
Edwards, Elizabeth;Livanos, Maria;Krueger, Anja;Dell, Anne;Haslam, Stuart M.;Smales, C. Mark;Bracewell, Daniel G. - 通讯作者:
Bracewell, Daniel G.
Editorial Commentary: Resistant hypertension: Pathogenesis and current and future management
- DOI:
10.1016/j.tcm.2016.06.004 - 发表时间:
2016-11-01 - 期刊:
- 影响因子:9.3
- 作者:
Edwards, Elizabeth;DiPette, Donald J. - 通讯作者:
DiPette, Donald J.
Development of a telehealth intervention to promote care-seeking among transgender women of color in Washington, DC
- DOI:
10.1111/phn.12709 - 发表时间:
2020-02-03 - 期刊:
- 影响因子:2.1
- 作者:
Magnus, Manya;Edwards, Elizabeth;Kuo, Irene - 通讯作者:
Kuo, Irene
"Real-world data analysis" in disease management such as hypertension: Has the time come?
- DOI:
10.1111/jch.13533 - 发表时间:
2019-05-01 - 期刊:
- 影响因子:2.8
- 作者:
Edwards, Elizabeth;DiPette, Donald J. - 通讯作者:
DiPette, Donald J.
Microalbuminuria in HIV Disease
- DOI:
10.1159/000350384 - 发表时间:
2013-01-01 - 期刊:
- 影响因子:4.2
- 作者:
Hadigan, Colleen;Edwards, Elizabeth;Kopp, Jeffrey B. - 通讯作者:
Kopp, Jeffrey B.
Edwards, Elizabeth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edwards, Elizabeth', 18)}}的其他基金
Anaerobic digestion of solid wastes: process enhancements; synergistic effect of food waste on digestibility of lignocellulosic fibres
固体废物的厌氧消化:工艺改进;
- 批准号:
530225-2018 - 财政年份:2021
- 资助金额:
$ 6.56万 - 项目类别:
Collaborative Research and Development Grants
Anaerobic digestion of solid wastes: process enhancements; synergistic effect of food waste on digestibility of lignocellulosic fibres
固体废物的厌氧消化:工艺改进;
- 批准号:
530225-2018 - 财政年份:2020
- 资助金额:
$ 6.56万 - 项目类别:
Collaborative Research and Development Grants
Anaerobic consortia and enzymes for biotransformation of aromatic compounds
用于芳香族化合物生物转化的厌氧菌群和酶
- 批准号:
RGPIN-2015-06663 - 财政年份:2019
- 资助金额:
$ 6.56万 - 项目类别:
Discovery Grants Program - Individual
Anaerobic digestion of solid wastes: process enhancements; synergistic effect of food waste on digestibility of lignocellulosic fibres
固体废物的厌氧消化:工艺改进;
- 批准号:
530225-2018 - 财政年份:2019
- 资助金额:
$ 6.56万 - 项目类别:
Collaborative Research and Development Grants
Improving Evaluation of Anaerobic Digestion Processes
改进厌氧消化过程的评估
- 批准号:
RTI-2020-00501 - 财政年份:2019
- 资助金额:
$ 6.56万 - 项目类别:
Research Tools and Instruments
Anaerobic consortia and enzymes for biotransformation of aromatic compounds
用于芳香族化合物生物转化的厌氧菌群和酶
- 批准号:
RGPIN-2015-06663 - 财政年份:2018
- 资助金额:
$ 6.56万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
基于非洲猪瘟病毒pS273R蛋白泛素-蛋白酶体降解途径阻抑机制理性设计其特异性蛋白水解靶向嵌合体的研究
- 批准号:32373044
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
原位矿化诱导中性粒细胞弹性蛋白酶ELANE介导Notch信号通路增效肺癌放疗的机制研究
- 批准号:82373199
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
口腔黏膜下纤维性变中赖氨酸羟化酶2异常活化抑制胶原降解的机制研究
- 批准号:82301102
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血管内皮细胞Mg2+/Mn2+依赖性蛋白磷酸酶1D基因突变在缺血性脑血管病中的作用机制研究
- 批准号:82371324
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
EGLN3羟化酶通过调控巨噬细胞重编程促进肺癌细胞EMT及转移的机制研究
- 批准号:82373030
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Probing the mechanisms of signal transduction via adiponectin and its receptors
脂联素及其受体信号转导机制的探讨
- 批准号:
7079917 - 财政年份:2006
- 资助金额:
$ 6.56万 - 项目类别: